Atlas Trials

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Clinical trial NCT02320032 · COMPLETED

Trial details

NCT number
NCT02320032
Sponsor
Alkermes, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-12-01
Primary completion
2016-04-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.